BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Bristol-Myers Squibb is in an uptrend]]>http://www.bloggingstocks.com/2009/12/03/bristol-myers-squibb-is-in-an-uptrend/http://www.bloggingstocks.com/2009/12/03/bristol-myers-squibb-is-in-an-uptrend/http://www.bloggingstocks.com/2009/12/03/bristol-myers-squibb-is-in-an-uptrend/#commentsFiled under: ,

Biopharmaceutical company Bristol-Myers Squibb (BMY) is performing on schedule, which is why I'm reiterating my buy rating for the company's shares, first recommended on June 1, 2009 at a price of $20.11. If you bought BMY in June, you're up about 24%.

Look for a 6-8% revenue increase for BMY in 2010, boosted by revenue gains in key proprietary drugs, led by Plavix (for the prevention of stroke, heart attack, and vascular disease). Also look for impressive results from new products Orencia (for rheumatoid arthritis) and Sprycel (for leukemia); BMY's nutritional products also should register a good year. The First Call FY2009/FY2010 EPS estimates for BMY are $2.02 to $2.21.

Continue reading Bristol-Myers Squibb is in an uptrend

Bristol-Myers Squibb is in an uptrend originally appeared on BloggingStocks on Thu, 03 Dec 2009 17:15:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>orenciapharmaceuticalsplavixsprycelThu, 03 Dec 2009 17:15:00 EST<![CDATA[It's still a good time to buy BMY]]>http://www.bloggingstocks.com/2009/09/23/its-still-a-good-time-to-buy-bmy/http://www.bloggingstocks.com/2009/09/23/its-still-a-good-time-to-buy-bmy/http://www.bloggingstocks.com/2009/09/23/its-still-a-good-time-to-buy-bmy/#commentsFiled under: ,

I'm reiterating my Buy rating for Bristol-Myers Squibb (NYSE: BMY), first recommended on June 1, 2009 at a price of $20.11.

The low, single-digit revenue growth story remains intact for Bristol-Myers Squibb in FY2009. Hence, place BMY in the category of a get-ahead-of-the-pack play.

Continue reading It's still a good time to buy BMY

It's still a good time to buy BMY originally appeared on BloggingStocks on Wed, 23 Sep 2009 17:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>bristol myers squibbBristolMyersSquibborenciaplavixsprycelWed, 23 Sep 2009 17:00:00 EST<![CDATA[Time to scoop up some shares of Bristol-Myers Squibb]]>http://www.bloggingstocks.com/2009/06/01/time-to-scoop-up-some-shares-of-bristol-myers-squibb/http://www.bloggingstocks.com/2009/06/01/time-to-scoop-up-some-shares-of-bristol-myers-squibb/http://www.bloggingstocks.com/2009/06/01/time-to-scoop-up-some-shares-of-bristol-myers-squibb/#commentsFiled under: ,

Readers of this space know that the investment bias is toward large-cap companies with demonstrated business models and who have a competitive advantage in established markets, preferably with a favorable, global trend as a support. And with that in mind, Bristol-Myers Squibb (NYSE: BMY) is worth a review.

In general, analysts forecast low, single-digit revenue growth for BMY in FY2009, weighed-down primarily by unfavorable foreign currency trends.

Continue reading Time to scoop up some shares of Bristol-Myers Squibb

Time to scoop up some shares of Bristol-Myers Squibb originally appeared on BloggingStocks on Mon, 01 Jun 2009 18:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>orenciapharmaceuticalsplavixsprycelMon, 01 Jun 2009 18:20:00 EST